New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2012
07:42 EDTCLDX, USPH, DXCM, INSM, IART, PBTH, AHS, CPHD, BIOS, ARNAOppenheimer to host a conference
23rd Annual Healthcare Conference is being held in New York on December 12-13 with webcasted presentations to begin on December 12 at 7:45 am; not all company presentations may be webcasted. Webcast Link
News For AHS;DXCM;ARNA;PBTH;USPH;BIOS;IART;CLDX;CPHD;INSM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 2, 2015
16:07 EDTARNAArena Pharmaceuticals reports Q4 EPS (15c), consensus (12c)
Subscribe for More Information
15:23 EDTARNANotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Mylan (MYL), consensus $1.05... Nabors Industries (NBR), consensus 39c... PRA Group (PRAA), consensus $1.11... Caesars Entertainment (CZR), consensus ($1.65)... Cumulus Media (CMLS), consensus 9c... Arena Pharmaceuticals (ARNA), consensus (12c)... Palo Alto Networks (PANW), consensus 17c... Guidewire Software (GWRE), consensus 11c... McDermott International (MDR), consensus (6c)... Salix Pharmaceuticals (SLXP), consensus (25c)... Matador Resources (MTDR), consensus 19c... Sanchez Energy (SN), consensus (11c).
12:11 EDTIARTIntegra LifeSciences targets long-term organic revenue growth 5%-7%
Subscribe for More Information
07:27 EDTIARTRaymond James to hold a conference
Subscribe for More Information
07:09 EDTBIOSBioScrip reports Q4 adjusted EPS (69c), consensus 1c
Reports Q4 revenue $253.68M, consensus $259.62M
February 27, 2015
08:04 EDTINSMInsmed reports Q4 EPS (36c), consensus (56c)
Subscribe for More Information
February 25, 2015
18:51 EDTCLDXCelldex 7.25M share Secondary priced at $24.00
Subscribe for More Information
16:50 EDTDXCMDexCom says Q1 usually 20% of year's revenue
16:45 EDTDXCMDexCom says Q1 is usually a slow quarter
Subscribe for More Information
16:43 EDTDXCMDexCom backs FY15 revenue view $340M-$360M, consensus $356.4M
Subscribe for More Information
16:04 EDTDXCMDexCom reports Q4 EPS 2c, consensus (3c)
Subscribe for More Information
February 24, 2015
16:00 EDTCLDXCelldex files to sell 7.25M shares of common stock
Subscribe for More Information
07:15 EDTCLDXCelldex reports Q4 EPS (36c), consensus (35c)
Subscribe for More Information
06:32 EDTIARTIntegra LifeSciences sees FY15 adjusted EPS $3.05-$3.23, consensus $3.27
Subscribe for More Information
06:32 EDTIARTIntegra LifeSciences reports Q4 adjusted EPS 94c, consensus 89c
Subscribe for More Information
February 23, 2015
10:18 EDTIARTIntegra LifeSciences management to meet with JMP Securities
Subscribe for More Information
09:25 EDTCLDXOn The Fly: Pre-market Movers
Subscribe for More Information
08:08 EDTCLDXCelldex rindopepimut receives FDA breakthrough therapy designation
Celldex Therapeutics announced that the FDA has granted rindopepimut Breakthrough Therapy Designation for the treatment of adult patients with EGFRvIII-positive glioblastoma, or GBM. This application was based on data from the Phase 2 ReACT study in recurrent GBM, the Phase 2 ACT III study in newly diagnosed GBM and additional supportive Phase 2 studies. An international Phase 3 study of rindopepimut, called ACT IV, in newly diagnosed GBM completed enrollment in December of 2014.
February 19, 2015
16:24 EDTAHSAMN Healthcare sees Q1 revenue $310M-$314M, consensus $275.11M
Sees Q1 gross margin is expected to be approximately 30.5%. SG&A expenses as a percentage of revenue are expected to be approximately 22.5%. Adjusted EBITDA margin is expected to be 8.5%-9.0%.
16:23 EDTAHSAMN Healthcare reports Q4 adjusted EPS 21c, consensus 18c
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use